UPDATE : Friday, May 29, 2020
Viromed finds prostate hyperplasia treatment effect in natural substance
A team of researchers at the Viromed’s natural product research group said ...
by Lee Han-soo  |  2018-12-11 14:55
Samsung BioLogics resumes trading despite controversies
The Korea Exchange (KRX) has decided to allow continued trading of Samsung ...
by Lee Han-soo  |  2018-12-11 10:50
Celltrion unveils clinical trial results for rituximab biosimilar in US
Celltrion Healthcare has presented a clinical trial, which showed the effic...
by Lee Han-soo  |  2018-12-06 11:11
Samsung BioLogics, Saint-Gobain sign supply agreement
Samsung BioLogics said Wednesday that it has signed a single-use raw materi...
by Lee Han-soo  |  2018-12-05 14:01
Chong Kun Dang launches world’s 1st 2nd-generation anemia biosimilar
Chong Kun Dang Pharmaceutical said Sunday that it has become the first comp...
by Lee Han-soo  |  2018-12-04 11:18
‘Rules to be tougher on patent transfer due to ToolGen case’
As the regulation on the patent transfer to a company from universities and...
by Nam Doo-hyun  |  2018-11-29 11:48
Celltrion wins FDA nod for rituximab biosimilar
Celltrion said Thursday that the U.S. Food and Drug Administration has appr...
by Lee Han-soo  |  2018-11-29 10:50
Samsung BioLogics files administrative suit to refute accounting fraud ruling
Samsung BioLogics said it filed an administrative suit on Nov. 14 to nullif...
by Nam Doo-hyun  |  2018-11-28 15:30
Pharmaceuticals, biotechs rise with KOSPI rebound
Shares of pharmaceutical and biotech companies moved up briskly on Monday, ...
by Nam Doo-hyun  |  2018-11-27 11:53
Celltrion’s Remsima tops global sale of ₩1 trillion
Celltrion Healthcare said Thursday that Remsima, a biosimilar of Remicade t...
by Lee Han-soo  |  2018-11-23 14:54
Operating income declines at top 10 biotechs on KOSDAQ
Top 10 biotech companies on the secondary KOSDAQ market posted significant ...
by Nam Doo-hyun  |  2018-11-22 11:15
Celltrion CEO involved in alleged ‘gapjil’ scandal
Celltrion Chairman Seo Jung-jin has reportedly pulled a power trip – ...
by Lee Han-soo  |  2018-11-21 16:02
US data crucial for Korean biosimilars after success in Europe
Korean biosimilar makers will find it more critical to achieve meaningful r...
by Nam Doo-hyun  |  2018-11-21 15:29
FDA OKs sale of Celltrion's HIV biosimilar
Temixys, a generic developed by Celltrion to treat the human immunodeficien...
by Lee Han-soo  |  2018-11-21 12:57
Intron Bio inks ₩750 billion licensing deal for anti-superbug drug
Intron Biotechnology said it has signed a landmark deal for an investigatio...
by So Jae-hyeon  |  2018-11-20 15:00
Celltrion Healthcare presents research results on using biosimilars in Europe
Celltrion Healthcare said Monday that it has presented the financial saving...
by Lee Han-soo  |  2018-11-19 16:57
Bridge Bio applies for idiopathic pulmonary fibrosis treatment in US
Bridge Biotherapeutic announced on Monday that the company has filed an inv...
by Lee Han-soo  |  2018-11-19 11:58
Tego Science sales plunge in Q3
Tego Science said Thursday that its sales plunged to 2.1 billion won ($1.8 ...
by Lee Han-soo  |  2018-11-16 14:54
NIBEC wins patent for novel peptide in US
Nano Intelligence Biomedical Engineering Corporation (NIBEC) has acquired a...
by Lee Han-soo  |  2018-11-16 14:40
Samsung BioLogics fiasco hardly affects biotech stocks
The suspension of trading of Samsung BioLogics shares did not have a much n...
by Nam Doo-hyun  |  2018-11-16 11:30
Back to Top